glucose, (beta-d)-isomer has been researched along with bezafibrate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dushkin, MI; Khoshchenko, OM; Posokhova, EN; Schvarts, YSh | 1 |
Kaneto, H; Matsuoka, TA; Miyatsuka, T; Shimo, N; Shimomura, I; Takahara, M; Takebe, S; Tochino, Y | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and bezafibrate
Article | Year |
---|---|
Agonists of PPAR-alpha, PPAR-gamma, and RXR inhibit the formation of foam cells from macrophages in mice with inflammation.
Topics: Alitretinoin; Animals; Bezafibrate; Cholesterol; Cholesterol Esters; Foam Cells; Inflammation; Injections, Intraperitoneal; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; PPAR alpha; PPAR gamma; Retinoid X Receptors; Rosiglitazone; Thiazolidinediones; Tretinoin; Triglycerides; Tumor Necrosis Factor-alpha; Zymosan | 2007 |
Short-term selective alleviation of glucotoxicity and lipotoxicity ameliorates the suppressed expression of key β-cell factors under diabetic conditions.
Topics: Animals; Apoptosis; Benzhydryl Compounds; Bezafibrate; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gene Expression; Glucose; Glucosides; Hypoglycemic Agents; Islets of Langerhans; Lipids; Mice | 2015 |